Fluvoxamine: a $4 Antidepressant That Reduces COVID 19 Hospitalizations

Study Finds Cheap, Generic Antidepressant May Lower Severe COVIDПодробнее

Antidepressant reduces hospitalisations and deathsПодробнее

Can the antidepressant 'fluvoxamine' reduce COVID-19 symptoms and hospitalizations?Подробнее

Study Shows Widely-Available Antidepressant Significantly Reduces COVID HospitalizationПодробнее

Fluvoxamine - A $5 Antidepressant That Fights COVIDПодробнее

Fluvoxamine for COVID-19: A New Weapon in the Fight?Подробнее

Antidepressant COVID-19 treatment shows promise in early study: FluvoxamineПодробнее

Fluvoxamine (antidepressant) effects on COVID-19 patients (Based on human trials)Подробнее

Researchers say one type of antidepressant could help with COVID-19 symptomsПодробнее

The TOGETHER Study Shows that Fluvoxamine Reduces Risk of Prolonged HospitalizationПодробнее

UT researchers look at antidepressant as potential treatment for COVID-19 symptomsПодробнее

$4 antidepressant shows promise against early COVID-19 symptoms; more study neededПодробнее

Fluvoxamine as a Treatment for COVID-19?Подробнее

New study finds antidepressant fluvoxamine does not help COVID-19 patients recover faster.Подробнее

Some antidepressants may lower risk of severe illness from COVID-19, study findsПодробнее

Doctor explains antidepressant tested as a COVID-19 treatmentПодробнее

SSRIs Prevent the Progression of COVID-19Подробнее

Fluvoxamine and COVID 19: what is the relationship? - IC@N ECHOПодробнее

$4 antidepressant shows promise against early COVID-19 symptoms; more study neededПодробнее

HealthWatch: Research Finds Fluvoxamine Cut Hospital Admissions For COVID-19 PatientsПодробнее